Chapter 1. Global Neurological Diagnostics Market – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. Global Neurological Diagnostics Market – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

       2.3.1. Impact during 2023 - 2030

       2.3.2. Impact on Supply – Demand

Chapter 3. Global Neurological Diagnostics Market – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. Global Neurological Diagnostics Market Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. Global Neurological Diagnostics Market - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. Global Neurological Diagnostics Market – By Type

6.1. Genomic

6.2. Proteomic

6.3. Metabolomic

6.4. Imaging

6.5. Others

Chapter 7. Global Neurological Diagnostics Market – By Technology

7.1. Neuroimaging Technologies

           7.1.1. Computed Tomography (CT)

          7 .1.2. Magnetic Resonance Imaging (MRI)

          7.1.3. Nuclear Medicine Imaging (PET, SPECT)

          7.1.4. Near Infrared Spectroscopic Imaging (NIRS)

          7.1.5. Electroencephalography (EEG)

          7.1.6. Magnetoencephalography (MEG)

          7.1.7. Voxel-based Morphometry (VBM)

7.2. In Vitro Diagnostics

            7.2.1. Biomarkers

            7.2.2. Biopsy

            7.2.3. Others

7.3. Neuroinformatics

Chapter 8. Global Neurological Diagnostics Market- By Disease Indication

8.1. Genetic Neurological Disorders

             8.1.1. Alzheimer’s Disease

             8.1.2. Parkinson’s Disease

             8.1.3. Amyotrophic Lateral Sclerosis

             8.1.4. Huntington’s Disease

             8.1.5. Others

8.2. Immunological Neurological Disorders

            8.2.1. Multiple Sclerosis

            8.2.2. Others

8.3. Paraproteinemic Neuropathies

8.4. Paraneoplastic Syndrome

8.5. Others

Chapter 9. Global Neurological Diagnostics Market- By End-User

8.1. Hospitals and Surgery Centers

8.2. Neurology Centers

8.3. Diagnostic Laboratories & Imaging Centers

8.4. Research Laboratories & Academic Institutes

8.5. Ambulatory Care Centers

8.6. Pharmaceutical and Biotechnology Companies

8.7. Others

Chapter 10. Global Neurological Diagnostics Market- By Region

10.1. North America

10.2. Europe

10.3. Asia-Pacific

10.4. Rest of the World

Chapter 11. Global Neurological Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. GE HealthCare

11. 2. Koninklijke Philips N.V.

11. 3. Siemens Healthcare GmbH

11. 4. Hitachi Ltd.

11. 5. Canon Inc.

11. 6. Lifelines Neuro

11. 7. Natus Medical Incorporated

11. 8. F. Hoffmann-La Roche Ltd.

11. 9. FUJIFILM Holdings Corporation

11. 10. Mitsar Co. LTD